CausalSentinel

Protein Dossier — LAG3 (Lymphocyte activation gene 3 protein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Eye problems or disorders: Injury or trauma resulting in loss of vision 0.541 0.126 1.83e-05 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.301 0.0848 3.80e-04 Wald ratio 1 cis NA
Cigarettes smoked per day -2.25 0.642 4.54e-04 Wald ratio 1 cis NA
Transferrin 0.206 0.0695 0.00305 Wald ratio 1 cis NA
Cancer code self-reported: malignant melanoma 0.35 0.133 0.00868 Wald ratio 1 cis NA
Femoral neck bone mineral density -0.136 0.0548 0.0132 Wald ratio 1 cis NA
Thalamus volume 100 41.2 0.0151 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] 0.256 0.107 0.0161 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.138 0.0587 0.0184 Wald ratio 1 cis NA
Eczema 0.241 0.115 0.0359 Wald ratio 1 cis NA
Non-cancer illness code self-reported: gout 0.23 0.11 0.037 Wald ratio 1 cis NA
Pallidum volume 25.5 12.7 0.0451 Wald ratio 1 cis NA
…and 73 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5099_14_3 LAG-3 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

38 association rows across 21 traits (37 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating LAG3 levels (id: OID01023_OID21315) 4e-160 rs3782735 4 GCST90860248 no MR -> candidate analysis
LAG3 protein levels 8e-160 rs3782735 3 GCST90469727 no MR -> candidate analysis
Circulating LAG3 levels (id: OID05553_OID21315) 9e-159 rs3782735 4 GCST90860765 no MR -> candidate analysis
Circulating CD4 levels (id: OID00466_OID20584) 2e-50 rs188343194 1 GCST90859827 no MR -> candidate analysis
Circulating CD4 levels (id: OID00776_OID20584) 2e-47 rs188343194 1 GCST90860110 no MR -> candidate analysis
Lymphocyte activation gene 3 protein levels 9e-32 rs3782735 1 GCST90248233 no MR -> candidate analysis
Sex hormone-binding globulin levels adjusted for BMI 1e-21 rs3782735 3 GCST90012110 no MR -> candidate analysis
Sex hormone-binding globulin levels 3e-18 rs3782735 7 GCST90012111 no MR -> candidate analysis
Phospholipids to Total Lipids in Very Large HDL percentage 1e-16 rs3782735 1 GCST90501303 no MR -> candidate analysis
Gamma glutamyl transferase levels 2e-16 rs3782735 1 GCST90428730 no MR -> candidate analysis
Gamma glutamyl transpeptidase 6e-16 rs3782735 1 GCST90018954 no MR -> candidate analysis
Gamma glutamyltransferase levels (UKB data field 30730) 8e-16 rs3782735 1 GCST90468070 no MR -> candidate analysis
…and 9 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 675 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Hashimoto thyroiditis 0.198 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 6 known modulators (Lymphocyte activation gene 3 protein)
gnomAD constraint pLI=7.5e-06, LOEUF=0.807 — LoF-tolerant
GWAS Catalog 74 unique SNPs / 148 rows
ClinVar 177 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance